Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
HALO combines two wavelengths of laser energy in a single session, making it the first treatment of its kind
Tirzepatide (Mounjaro/Zepbound) followed the same path
The SURMOUNT-1 trial , published in the New England Journal of Medicine , showed tirzepatide at its highest dose achieved average weight reductions of 22.5% over 72 weeks making it the most effective FDA-approved weight loss medication available
The US investigation is still ongoing, however, and has been broadened to include Lillys dual GLP-1/GIP agonist tirzepatide, approved as Mounjaro for obesity and Zepbound for obesity
They continue drawing the same number of units as before without realizing the concentration has changed
